Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery

Circulation

Volumn 103, Issue 25, 2001, Pages 3069-3074

  Huynh, Thao ^a   Théroux, Pierre ^b   Bogaty, Peter ^d   Nasmith, James ^c   Solymoss, Susan ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

Anticoagulants; Aspirin; Coronary disease; Warfarin sodium

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REVASCULARIZATION; RISK FACTOR; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 0035954275     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.25.3069     Document Type: Article

References (30)

1. Preoperative and operative predictive variables of late clinical events following saphenous vein coronary artery bypass graft surgery
2. Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris
3. Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery
4. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in myocardial ischemia III registry)
5. A platelet-inhibitor drug trial in coronary artery bypass operations: Benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency
6. Effect of dipyridamole and aspirin on late vein graft patency after coronary bypass operation
7. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts: A double-blind, placebo-controlled, randomized trial
8. Starting aspirin therapy after operation: Effects on early patency
9. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery
10. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion
11. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: A comparison of low-dose aspirin, low-dose aspirin plus dipyridamole and oral anticoagulants
12. Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusion
13. Anticoagulant treatment in unstable angina
14. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery
15. Percutaneous angioscopy of saphenous vein coronary bypass grafts
16. Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein grafts with intracoronary angioscopy in patients with unstable angina
17. Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischemic heart disease in men at increased risk
18. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous vein coronary artery bypass grafts
19. Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
20. The Post CABG investigators: Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the Post Coronary Artery Bypass Graft trial
21. Coronary artery flow ten weeks after myocardial infarction or unstable angina: Effects of combined warfarin and aspirin therapy
22. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: Primary end points analysis from the ATACS trial: Antithrombotic therapy in Acute Coronary Syndromes Research Group
23. The OASIS Pilot Study Investigators: Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q wave myocardial infarction
24. Effects of long-term and moderate-intensity oral anticoagulation in addition to aspirin in unstable angina
25. Rapid changes in the coagulant proteins on saphenous vein endothelium in response to arterial flow
26. Plasminogen activator inhibitor-I in neointima of vein grafts: Its role in reduced fibrinolytic potential and graft failure
27. A murine model of myocardial microvascular thrombosis
28. Unfractionated heparin and low molecular weight heparin in acute coronary syndromes without ST elevation: A meta-analysis
29. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study: FRagmin and Fast Revascularisation during InStability in Coronary artery disease
30. Clopidogrel in the Unstable Angina to Prevent Recurrent ischemic Events (CURE)